KRMD
Price
$3.16
Change
+$0.01 (+0.32%)
Updated
Sep 11 closing price
Capitalization
145.45M
60 days until earnings call
Intraday BUY SELL Signals
NVST
Price
$25.55
Change
-$0.32 (-1.24%)
Updated
Sep 11 closing price
Capitalization
4.1B
53 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

KRMD vs NVST

KRMD vs NVST Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
KRMD vs. NVST commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KRMD is a Hold and NVST is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NVST($4.1B) has a higher market cap than KRMD($145M). NVST YTD gains are higher at: 17.688 vs. KRMD (-45.611). NVST has higher annual earnings (EBITDA): 421M vs. KRMD (-861.5K). NVST has more cash in the bank: 1.13B vs. KRMD (8.29M). KRMD has less debt than NVST: KRMD (3.31M) vs NVST (1.59B). NVST has higher revenues than KRMD: NVST (2.86B) vs KRMD (45.1M).
KRMDNVSTKRMD / NVST
Capitalization145M4.1B4%
EBITDA-861.5K421M-0%
Gain YTD-45.61117.688-258%
P/E RatioN/A44.05-
Revenue45.1M2.86B2%
Total Cash8.29M1.13B1%
Total Debt3.31M1.59B0%
FUNDAMENTALS RATINGS
KRMD vs NVST: Fundamental Ratings
KRMD
NVST
OUTLOOK RATING
1..100
1761
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
56
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9487
PRICE GROWTH RATING
1..100
7752
P/E GROWTH RATING
1..100
3683
SEASONALITY SCORE
1..100
5090

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NVST's Valuation (56) in the null industry is in the same range as KRMD (88). This means that NVST’s stock grew similarly to KRMD’s over the last 12 months.

NVST's Profit vs Risk Rating (100) in the null industry is in the same range as KRMD (100). This means that NVST’s stock grew similarly to KRMD’s over the last 12 months.

NVST's SMR Rating (87) in the null industry is in the same range as KRMD (94). This means that NVST’s stock grew similarly to KRMD’s over the last 12 months.

NVST's Price Growth Rating (52) in the null industry is in the same range as KRMD (77). This means that NVST’s stock grew similarly to KRMD’s over the last 12 months.

KRMD's P/E Growth Rating (36) in the null industry is somewhat better than the same rating for NVST (83). This means that KRMD’s stock grew somewhat faster than NVST’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KRMDNVST
RSI
ODDS (%)
Bullish Trend 2 days ago
65%
Bullish Trend 2 days ago
63%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
76%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
67%
MACD
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
70%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
69%
Advances
ODDS (%)
Bullish Trend 13 days ago
79%
Bullish Trend 10 days ago
66%
Declines
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 2 days ago
69%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
78%
Bullish Trend 2 days ago
64%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
76%
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (KRMD: $3.16 vs. NVST: $25.55)
Brand notoriety: KRMD and NVST are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: KRMD: 46% vs. NVST: 147%
Market capitalization -- KRMD: $145.45M vs. NVST: $4.1B
KRMD [@Pharmaceuticals: Other] is valued at $145.45M. NVST’s [@Pharmaceuticals: Other] market capitalization is $4.1B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $126 to $130.41B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $8.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KRMD’s FA Score shows that 0 FA rating(s) are green while NVST’s FA Score has 0 green FA rating(s).

  • KRMD’s FA Score: 0 green, 5 red.
  • NVST’s FA Score: 0 green, 5 red.
According to our system of comparison, KRMD is a better buy in the long-term than NVST.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KRMD’s TA Score shows that 5 TA indicator(s) are bullish while NVST’s TA Score has 4 bullish TA indicator(s).

  • KRMD’s TA Score: 5 bullish, 4 bearish.
  • NVST’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, KRMD is a better buy in the short-term than NVST.

Price Growth

KRMD (@Pharmaceuticals: Other) experienced а -2.77% price change this week, while NVST (@Pharmaceuticals: Other) price change was -6.34% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -3.51%. For the same industry, the average monthly price growth was -3.46%, and the average quarterly price growth was +12.67%.

Reported Earning Dates

KRMD is expected to report earnings on Nov 11, 2026.

NVST is expected to report earnings on Nov 04, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (-3.51% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

View a ticker or compare two or three
KRMD
Daily Signal:
Gain/Loss:
NVST
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HGHSX46.88N/A
N/A
Hartford Healthcare R4
BMPSX105.46N/A
N/A
ProFunds Materials UltraSector Svc
GAOAX21.61N/A
N/A
JPMorgan Global Allocation A
FIAWX33.69N/A
N/A
Fidelity Advisor® Equity Dividend Inc Z
MYITX11.84-0.03
-0.25%
NYLIM WMC International Research Eq Cl A

KRMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, KRMD has been loosely correlated with QDEL. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if KRMD jumps, then QDEL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KRMD
1D Price
Change %
KRMD100%
+0.32%
QDEL - KRMD
40%
Loosely correlated
-3.05%
A - KRMD
40%
Loosely correlated
+2.66%
CLPT - KRMD
39%
Loosely correlated
+1.78%
BIO - KRMD
38%
Loosely correlated
+0.15%
NVST - KRMD
35%
Loosely correlated
-1.24%
More